CD8A and neoplasm: The DPPA-TRPP/Tab nanoplatform improved the compound's tumor accumulation, suppressed CAFs formation, reduced immunosuppressive cytokine secretion, promoted CD8+ CD4+ T cell infiltration and decreased Tregs distribution, resulting in a potent antitumor effect.